NCT02252770View on ClinicalTrials.gov

Nitric Oxide Supplementation in Argininosuccinic Aciduria

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Argininosuccinic AciduriaArgininosuccinate Lyase DeficiencyUrea Cycle Disorders
Interventions
DIETARY_SUPPLEMENT

Nitric oxide supplement

Each active comparator supplement is an all natural nitric oxide supplement. Subjects will take one lozenge twice a day.

DIETARY_SUPPLEMENT

Placebo

Placebo will not contain nitric oxide supplement.

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT02252770 - Nitric Oxide Supplementation in Argininosuccinic Aciduria | Biotech Hunter | Biotech Hunter